Cheung AK, et al. International consensus on standardized clinic blood pressure measurement—a call to action. Am J Med 2023; 136:438–445.e1. doi: 10.1016/j.amjmed.2022.12.015
Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: An individual participant-level data meta-analysis. Lancet 2021; 397:1625–1636. doi: 10.1016/S0140-6736(21)00590-0
Drawz PE, et al. Concordance between blood pressure in the Systolic Blood Pressure Intervention Trial and in routine clinical practice. JAMA Intern Med 2020; 180:1655–1663. doi: 10.1001/jamainternmed.2020.5028
Siu AL; U.S. Preventive Services Task Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015; 163:778–786. doi: 10.7326/M15-2223
Parati G, et al. Masked-Uncontrolled Hypertension Management Based on Office BP or on Ambulatory Blood Pressure Measurement (MASTER) study: A randomised controlled trial protocol. BMJ Open 2018; 8:e021038. doi: 10.1136/bmjopen-2017-021038
Egan BM, et al. Improving hypertension control in primary care with the measure accurately, act rapidly, and partner with patients protocol. Hypertension 2018; 72:1320–1327. doi: 10.1161/HYPERTENSIONAHA.118.11558
Jaffe MG, Young JD. The Kaiser Permanente Northern California story: Improving hypertension control from 44% to 90% in 13 years (2000 to 2013). J Clin Hypertens (Greenwich) 2016; 18:260–261. doi: 10.1111/jch.12803
Sakhuja S, et al. Potential impact of systematic and random errors in blood pressure measurement on the prevalence of high office blood pressure in the United States. J Clin Hypertens (Greenwich) 2022; 24:263–270. doi: 10.1111/jch.14418
Picone DS, et al. How to find and use validated blood pressure measuring devices. J Hum Hypertens 2023; 37:108–114. https://www.nature.com/articles/s41371-022-00718-5